300. IgG4-related disease Clinical trials / Disease details


Clinical trials : 36 Drugs : 49 - (DrugBank : 22) / Drug target genes : 16 - Drug target pathways : 98

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04520451
(ClinicalTrials.gov)
August 22, 202011/8/2020Open Label Two-Arm Study to Evaluate Rilzabrutinib (PRN1008) in IgG4-Related Disease PatientsAn Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patients With IgG4-Related DiseaseIgG4-Related DiseaseDrug: rilzabrutinib;Drug: GlucocorticoidsPrincipia Biopharma, a Sanofi CompanyMassachusetts General HospitalRecruiting18 YearsN/AAll25Phase 2United States;Canada